Climate Action Could Avert Nearly Half The World’s Premature Deaths
GHI Director Jonathan Patz looks at health opportunities from a low-carbon economy.
GHI Director Jonathan Patz looks at health opportunities from a low-carbon economy.
GHI Director Jonathan Patz joins state health professionals in looking for a shift to a clean economy to prevent disease and death.
Everyone knows walking and bicycling is good for the health of a community, but how good? And how can city planners measure those impacts to champion bicycle and walking infrastructure? At the University of Wisconsin-Madison Global Health Institute, Samuel Younkin, lead researcher for the Initiative for Health-Oriented Transportation (HOT), and colleagues created a new model …
Krishna Ella, scientist, successful entrepreneur in the field of vaccines and a member of GHI's Board of Visitors, will receive an honorary degree from UW-Madison at spring commencement.
GHI Director Jonathan Patz discusses how actions on climate crisis benefit health.
Now in its seventh year, University of Wisconsin-Madison’s UniverCity Year program is working with six communities stretching from the neighboring City of Stoughton to Polk County in northwest Wisconsin. UniverCity Year (UCY) is the hallmark program of UniverCity Alliance–an initiative that connects local governments across Wisconsin with resources at the university. Through the three-year UCY …
Watch the presentations from the four finalists for the GHI Director position.
The drugs behind the new pills to treat COVID-19 remain very effective against the omicron variant of the virus in lab tests, according to a new study. However, lab tests also showed that the available antibody therapies — typically given intravenously in hospitals — are substantially less effective against omicron than against earlier variants of …
A new study confirms that, compared to earlier versions of the SARS-CoV-2 virus, the omicron variant causes less severe disease in mice and hamsters, which are reliable models for understanding COVID-19. The findings, previously available as a preprint and published following peer review today (Jan. 21) in the journal Nature, align with preliminary data from …
The National Institutes of Health is investing in three teams working to develop a vaccine against a broad range of coronaviruses. Among them is a research collaboration, the Pan-Coronavirus Vaccine consortium, led by UW–Madison School of Veterinary Medicine Professor of Pathobiological Sciences Yoshihiro Kawaoka, who is also a GHI Advisory Committee member.